Phase II study of olaparib in previously treated advanced solid tumours with homologous recombination repair mutation (HRRm) or homologous recombination repair deficiency (HRD): LYNK-002 Meeting Abstract
| Authors: | Hyman, D.; Hendifar, A.; Cheol Chung, H.; Maio, M.; Leary, A.; Spanggaard, I.; Rhee, J.; Marton, M.; Chen, M.; Krishnan, S.; Shapira, R. |
| Abstract Title: | Phase II study of olaparib in previously treated advanced solid tumours with homologous recombination repair mutation (HRRm) or homologous recombination repair deficiency (HRD): LYNK-002 |
| Meeting Title: | 44th ESMO Congress (ESMO 2019) |
| Journal Title: | Annals of Oncology |
| Volume: | 30 |
| Issue: | Suppl. 5 |
| Meeting Dates: | 2019 Sep 27-Oct 1 |
| Meeting Location: | Barcelona, Spain |
| ISSN: | 0923-7534 |
| Publisher: | Oxford University Press |
| Date Published: | 2019-10-01 |
| Start Page: | mdz239.078 |
| Language: | English |
| ACCESSION: | WOS:000491295500379 |
| PROVIDER: | wos |
| DOI: | 10.1093/annonc/mdz239.078 |
| Notes: | Meeting Abstract: 171TiP -- Appears on pages v53-v54 of the abstract book -- Source: Wos |
